Research Diagnosis Related Groups (DRG) level mortality quality outcomes for Northwestern Lake Forest Hospital located at 660 N Westmoreland Rd, Lake Forest, IL, 60045 & includes data from NPIs 1124025176
Oct 2016 to Sep 2019 | Oct 2018 to Sep 2019
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 9,484 | 8,931 | ||||||||||||||||||||||
| Surgical | 2,782 | 2,695 | ||||||||||||||||||||||
| Non Surgical | 6,702 | 6,236 | ||||||||||||||||||||||
| Orthopedics | 1,848 | 1,820 | ||||||||||||||||||||||
| Cardiovascular | 1,678 | 1,522 | ||||||||||||||||||||||
| General Medicine | 1,660 | 1,524 | ||||||||||||||||||||||
| Gastroenterology & Endocrinology | 1,009 | 960 | ||||||||||||||||||||||
| Pulmonology | 881 | 837 | ||||||||||||||||||||||
| Urology | 654 | 629 | ||||||||||||||||||||||
| Neurology | 510 | 469 | ||||||||||||||||||||||
| General Surgery | 390 | 361 | ||||||||||||||||||||||
| Oncology & Hematology | 356 | 325 | ||||||||||||||||||||||
| Obstetrics & Gynecology | 137 | 136 | ||||||||||||||||||||||
| Colorectal | 127 | 123 | ||||||||||||||||||||||
| Spine | 106 | 105 | ||||||||||||||||||||||
| Psychiatry & Mental Disorders | 75 | 69 | ||||||||||||||||||||||
| Dermatology | 48 | 46 |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 469: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 480: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 482: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||||||||||||||
| DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 468: REVISION OF HIP OR KNEE REPLACEMENT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy | ||||||||||||||||||||||||
| DRG 543: PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 542: PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Medical Back Problems | ||||||||||||||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||||||||||||||
| Lower Extremity And Humerus Procedures Except Hip,Foot,Femur | ||||||||||||||||||||||||
| DRG 493: LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 494: LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||||||||||||||
| DRG 516: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 517: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Fracture, Sprain, Strain And Dislocation Except Femur, Hip, Pelvis And Thigh | ||||||||||||||||||||||||
| DRG 563: FRACTURE SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Fractures Of Hip And Pelvis | ||||||||||||||||||||||||
| DRG 536: FRACTURES OF HIP AND PELVIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Soft Tissue Procedures | ||||||||||||||||||||||||
| DRG 501: SOFT TISSUE PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||||||||||||||
| DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Bone Diseases And Arthropathies | ||||||||||||||||||||||||
| DRG 554: BONE DISEASES AND ARTHROPATHIES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Biopsies Of Musculoskeletal System And Connective Tissue | ||||||||||||||||||||||||
| DRG 478: BIOPSIES OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Amputation Of Lower Limb For Endocrine, Nutritional And Metabolic Disorders | ||||||||||||||||||||||||
| DRG 617: AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Connective Tissue Disorders | ||||||||||||||||||||||||
| Amputation For Circulatory System Disorders Except Upper Limb And Toe | ||||||||||||||||||||||||
| Knee Procedures | ||||||||||||||||||||||||
| Tendonitis, Myositis And Bursitis | ||||||||||||||||||||||||
| Other Musculoskeletal System And Connective Tissue Diagnoses |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 293: HEART FAILURE AND SHOCK WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||||||||||||||
| Acute Myocardial Infarction | ||||||||||||||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 282: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Peripheral Vascular Disorders | ||||||||||||||||||||||||
| DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 299: PERIPHERAL VASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 301: PERIPHERAL VASCULAR DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Permanent Cardiac Pacemaker Implant | ||||||||||||||||||||||||
| DRG 243: PERMANENT CARDIAC PACEMAKER IMPLANT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 242: PERMANENT CARDIAC PACEMAKER IMPLANT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 244: PERMANENT CARDIAC PACEMAKER IMPLANT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||||||||||||||
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 315: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Other Vascular Procedures | ||||||||||||||||||||||||
| DRG 253: OTHER VASCULAR PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Major Cardiovascular Procedures | ||||||||||||||||||||||||
| DRG 270: OTHER MAJOR CARDIOVASCULAR PROCEDURES W MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Hypertension | ||||||||||||||||||||||||
| DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 304: HYPERTENSION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Syncope And Collapse | ||||||||||||||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||||||||||||||
| Atherosclerosis | ||||||||||||||||||||||||
| DRG 303: ATHEROSCLEROSIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Cardiac Congenital And Valvular Disorders | ||||||||||||||||||||||||
| Chest Pain | ||||||||||||||||||||||||
| DRG 313: CHEST PAIN |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 870: SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | ||||||||||||||||||||||||
| Cellulitis | ||||||||||||||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 602: CELLULITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Postoperative And Post-Traumatic Infections | ||||||||||||||||||||||||
| DRG 863: POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 862: POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Otitis Media And Upper Respiratory Infection | ||||||||||||||||||||||||
| DRG 153: OTITIS MEDIA AND URI WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Complications Of Treatment | ||||||||||||||||||||||||
| DRG 920: COMPLICATIONS OF TREATMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 919: COMPLICATIONS OF TREATMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||||||||||||||
| DRG 441: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 442: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Poisoning And Toxic Effects Of Drugs | ||||||||||||||||||||||||
| DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Cirrhosis And Alcoholic Hepatitis | ||||||||||||||||||||||||
| DRG 432: CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 433: CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Signs And Symptoms | ||||||||||||||||||||||||
| DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Viral Illness | ||||||||||||||||||||||||
| Disequilibrium | ||||||||||||||||||||||||
| DRG 149: DYSEQUILIBRIUM | ||||||||||||||||||||||||
| Other Ear,Nose,Mouth And Throat Diagnoses | ||||||||||||||||||||||||
| Fever And Inflammatory Conditions | ||||||||||||||||||||||||
| DRG 864: FEVER |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| G.I.Hemorrhage | ||||||||||||||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 379: G.I. HEMORRHAGE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| G.I. Obstruction | ||||||||||||||||||||||||
| DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 390: G.I. OBSTRUCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 388: G.I. OBSTRUCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Digestive System Diagnoses | ||||||||||||||||||||||||
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 395: OTHER DIGESTIVE SYSTEM DIAGNOSES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||||||||||||||
| DRG 372: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 371: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Endocrine Disorders | ||||||||||||||||||||||||
| DRG 643: ENDOCRINE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 644: ENDOCRINE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 645: ENDOCRINE DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Diabetes | ||||||||||||||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Disorders Of Biliary Tract | ||||||||||||||||||||||||
| DRG 445: DISORDERS OF THE BILIARY TRACT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 444: DISORDERS OF THE BILIARY TRACT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Disorders Of Pancreas Except Malignancy | ||||||||||||||||||||||||
| DRG 439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 438: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 440: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Cholecystectomy | ||||||||||||||||||||||||
| DRG 418: LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 419: LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Inflammatory Bowel Disease | ||||||||||||||||||||||||
| DRG 386: INFLAMMATORY BOWEL DISEASE WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 195: SIMPLE PNEUMONIA AND PLEURISY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Pulmonary Embolism | ||||||||||||||||||||||||
| DRG 176: PULMONARY EMBOLISM WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 175: PULMONARY EMBOLISM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||||||||||||||
| Bronchitis And Asthma | ||||||||||||||||||||||||
| DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 203: BRONCHITIS AND ASTHMA WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Interstitial Lung Disease | ||||||||||||||||||||||||
| DRG 196: INTERSTITIAL LUNG DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Major Chest Trauma | ||||||||||||||||||||||||
| Pneumothorax | ||||||||||||||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||||||||||||||
| DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||||||||||||||
| Other Respiratory System Diagnoses |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Kidney And Ureter Procedures | ||||||||||||||||||||||||
| DRG 659: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Other Kidney And Urinary Tract Procedures | ||||||||||||||||||||||||
| DRG 673: OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Urinary Stones | ||||||||||||||||||||||||
| DRG 694: URINARY STONES WITHOUT ESW LITHOTRIPSY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Transurethral Procedures | ||||||||||||||||||||||||
| Major Male Pelvic Procedures |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||||||||||||||
| DRG 066: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 056: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Disorders Of Nervous System | ||||||||||||||||||||||||
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||||||||||||||
| DRG 086: TRAUMATIC STUPOR AND COMA, COMA <1 HOUR WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Nonspecific Cerebrovascular Disorders | ||||||||||||||||||||||||
| DRG 071: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 070: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Cranial And Peripheral Nerve Disorders | ||||||||||||||||||||||||
| DRG 074: CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Seizures | ||||||||||||||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Transient Ischemia | ||||||||||||||||||||||||
| DRG 069: TRANSIENT ISCHEMIA | ||||||||||||||||||||||||
| Nonspecific Cva And Precerebral Occlusion Without Infarction | ||||||||||||||||||||||||
| Headaches |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 854: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Other Respiratory System O.R. Procedures | ||||||||||||||||||||||||
| DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 167: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||||||||||||||
| DRG 464: WOUND DEBRIDEMENT AND SKIN GRAFT EXCEPT HAND FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Postoperative Or Post-Traumatic Infections With O.R. Procedure | ||||||||||||||||||||||||
| DRG 857: POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Other Skin, Subcutaneous Tissue And Breast Procedures | ||||||||||||||||||||||||
| DRG 580: OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||||||||||||||
| Extracranial Procedures | ||||||||||||||||||||||||
| DRG 039: EXTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Appendectomy | ||||||||||||||||||||||||
| Other Digestive System O.R. Procedures | ||||||||||||||||||||||||
| Non-Extensive Procedure Unrelated To Principal Diagnosis | ||||||||||||||||||||||||
| Craniotomy And Endovascular Intracranial Procedures | ||||||||||||||||||||||||
| Hernia Procedures | ||||||||||||||||||||||||
| Lymphoma And Non-Acute Leukemia With Other Procedure |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Digestive Malignancy | ||||||||||||||||||||||||
| DRG 374: DIGESTIVE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 375: DIGESTIVE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Respiratory Neoplasms | ||||||||||||||||||||||||
| DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Malignancy Of Hepatobiliary System Or Pancreas | ||||||||||||||||||||||||
| DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Lymphoma And Non-Acute Leukemia | ||||||||||||||||||||||||
| DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | ||||||||||||||||||||||||
| DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||||||||||||||
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Nervous System Neoplasms | ||||||||||||||||||||||||
| DRG 054: NERVOUS SYSTEM NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Other Myeloproliferative Disorders Or Poorly Differentiated Neoplasm Diagnoses | ||||||||||||||||||||||||
| Coagulation Disorders | ||||||||||||||||||||||||
| DRG 813: COAGULATION DISORDERS |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uterine And Adnexal Procedures For Malignancy | ||||||||||||||||||||||||
| DRG 741: UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 740: UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 737: UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Uterine And Adnexal Procedures For Non-Malignancy | ||||||||||||||||||||||||
| DRG 743: UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Vagina, Cervix And Vulva Procedures |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spinal Fusion Except Cervical | ||||||||||||||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Cervical Spinal Fusion | ||||||||||||||||||||||||
| DRG 473: CERVICAL SPINAL FUSION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| DRG 472: CERVICAL SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
| Combined Anterior/Posterior Spinal Fusion | ||||||||||||||||||||||||
| Back And Neck Procedures, Except Spinal Fusion, Or Disc Devices/Neurostimulators |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcohol/Drug Abuse Or Dependence | ||||||||||||||||||||||||
| DRG 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Organic Disturbances And Intellectual Disability | ||||||||||||||||||||||||
| DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trauma To The Skin, Subcutaneous Tissue And Breast | ||||||||||||||||||||||||
| DRG 605: TRAUMA TO THE SKIN, SUBCUTANEOUS TISSUE AND BREAST WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
| Skin Ulcers |